Concomitant inactivation of p53 and Chk2 in breast cancer (Q57278104)

10

0 references

author name string

Alexandra Sullivan

1

0 references

Claire Repellin

3

0 references

Archana Reddy

4

0 references

Olivier Reelfs

5

0 references

Alexandra Bell

6

0 references

Barbara Dunne

7

0 references

Barry A Gusterson

8

0 references

Peter Osin

9

0 references

Isik Yulug

11

0 references

Abigail Evans

12

0 references

Tayfun Ozcelik

13

0 references

Milena Gasco

14

0 references

Tim Crook

Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27.

15

0 references

language of work or name

English

0 references

publication date

February 2002

0 references

published in

Oncogene

0 references

volume

21

0 references

issue

9

0 references

page(s)

1316-1324

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Mutation analysis of the CHK2 gene in families with hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Breast cancer genetics: what we know and what we need

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Screening hCHK2 for Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Characterization of tumor-associated Chk2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

Methylation-independent silencing of the p73 gene in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

7 January 2021

Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

7 January 2021

p53 mutation as a genetic trait of typical medullary breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

7 January 2021

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

7 January 2021

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

7 January 2021

Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205207

7 January 2021